Insulin treatment persistence varies among payers March 25, 2017By Tracey WalkerA study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States. Five pharmacy regulations health execs must keep on their radars in 2017 March 19, 2017By Kenneth MaxikHere are five critical regulations that executives can begin to prepare for today. ACA reform must preserve mental health pharmacy access March 12, 2017By John FigueroaACA repeal or replacement must focus on how to preserve mental health services and pharmacy access. New strategies for managing drug spend: RA, Cancer, Hep C
March 04, 2017The proliferation of specialty drugs has prompted new techniques for keeping costs in tow.
Express Scripts’ 2016 Drug Trend Report: 7 things to know February 13, 2017By Tracey WalkerReport highlights spending trends in key areas, including specialty medications, oncology, diabetes, and inflammatory conditions. Top 3 pharmacy challenges in 2017: Two-pronged solutionHere are three pharmacy challenges facing healthcare executives and a two-pronged solution to help solve them. Top challenges in cancer care January 14, 2017By Tracey WalkerCancer drug costs remain the most critical challenge in care, among other things. What billions in lost pharma revenue means for managed care December 12, 2016By Marc O'ConnorPharmaceutical manufacturer relationships and next-gen value based contracts are primed to accelerate value-derivation from your drug spend. Large variety of multiple myeloma treatment options presents challenges December 06, 2016By Bryant FurlowThere now exist numerous treatment options for multiple myeloma but how best to sequence them is still under study Hodgkin lymphoma: First hematologic cancer cured with immunotherapy? December 05, 2016By Bryant FurlowImmune checkpoint inhibitors are taking the stage in treating relapsed and refractory Hodgkin lymphoma. Read more.